Guam vs Marshall Islands: The number of people with susceptibility test result for rifampicin
Guam
35
in 2021
Marshall Islands
31
in 2021
Guam rank
126th
Marshall Islands rank
127th
The number of people with susceptibility test result for rifampicin over time
- Guam
- Marshall Islands
How they compare
Guam currently reports 35 against 31 in Marshall Islands, a difference of 4.
That makes Guam's figure about 1.1 times Marshall Islands's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Marshall Islands ahead.
Guam ranks 126th and Marshall Islands ranks 127th of 155 countries.
Across the 2 decades both report, Guam averaged higher in 1 and Marshall Islands in 1.
Head to head by decade
| Decade | Guam | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 50.33 | 54 | 3.67 | Marshall Islands |
| 2020s | 36.5 | 25.5 | 11 | Guam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guam or Marshall Islands?
- Guam, at 35 against 31 in Marshall Islands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guam and Marshall Islands?
- 4, with Guam ahead.
- How many years of comparable data are there for Guam and Marshall Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Guam and Marshall Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Guam ranks 126th and Marshall Islands ranks 127th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.